Type 1 Diabetes
Advanced glycation endproducts correlate with diabetes complications
Published in Obesity and Diabetes Week, March 10th, 2003
"We investigated whether serum levels of N-(carboxymethyl)lysine (CML), non-CML advanced glycation endproducts (AGEs), or pentosidine are associated with severity of diabetic microvascular complications in patients with type I diabetes," researchers in Japan reported.
"Serum levels of CML, non-CML AGE, and pentosidine were measured by an enzyme-linked immunosorbent assay in 38 males, and 47 females aged 31±8 years (mean±S.D.) with type 1 diabetes for 18.7±7.0 years," said J. Miura and colleagues, Tokyo Women's Medical University, School of Medicine.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Adiposity
Classification of adipose tissue quantification by imaging methods proposed - Type 1 Diabetes
Proposed treatment for diabetes could have devastating side effects - Body Composition
Magnitude of fat-free mass density determined by body composition modeling study - Complementary and Alternative Medicine
Mind-body interventions can improve vascular complications of diabetes - Heart Disease Risk Factor
Obese men have reduced aortic elasticity - Obesity Genomics and Genetics
Intracellular retention common in childhood obesity-associated MC4R mutations - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
